|
|
 |
|
Viewing report
|
|
|
|
Antivirals - Global Strategic Business Report
Global Industry Analysts, Inc, Oct 2006, Pages: 699
This report analyzes the worldwide markets for Antivirals in US$ Million. The major product segments analyzed are HIV Antivirals (Reverse Transcriptase Inhibitors (RTIs) (Nucleotide Reverse Transcriptase Inhibitors (NRTIs), and Non-Nucleotide Reverse Transcriptase Inhibitors (NNRTIs)), and Protease Inhibitors (PIs), Hepatitis B & C Antivirals (Hepatitis C Antivirals, and Hepatitis B Antivirals), Herpes Simplex Virus (HSV) Antivirals, Influenza Antivirals, Respiratory Syncytial Virus (RSV) Antivirals, and Human Papilloma Virus (HPV) Antivirals. The report provides separate comprehensive analytics for the US, Japan, Europe and Rest of World. Annual forecasts are provided for the period of 2000 through 2010. The report profiles 139 companies including many key and niche players worldwide such as Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline Plc., Hoffmann-La Roche, Merck & Co., Novartis AG, Pfizer Inc., Schering-Plough Corp. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on 'Enquire before buying'
|
|
|
|
